{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "MERS", "SARS", "SARS-CoV-2", "coronavirus", "immunity", "ozone"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34677149", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "08"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.4103/2045-9912.325989"], "Journal": {"ISSN": "2045-9912", "JournalIssue": {"Volume": "12", "Issue": "2", "PubDate": {"Year": "2022", "Season": "Apr-Jun"}}, "Title": "Medical gas research", "ISOAbbreviation": "Med Gas Res"}, "ArticleTitle": "Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease.", "Pagination": {"StartPage": "33", "EndPage": "40", "MedlinePgn": "33-40"}, "Abstract": {"AbstractText": ["Atmospheric ozone is produced when nitrogen oxides react with volatile organic compounds. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome contains a unique N-terminal fragment in the Spike protein, which allows it to bind to air pollutants in the environment. 'Our approach in this review is to study ozone and its effect on the SARS-CoV-2 virus and patients with coronavirus disease 2019 (COVID-19). Article data were collected from PubMed, Scopus, and Google Scholar databases. Ozone therapy has antiviral properties, improves blood flow, facilitates the transfer of oxygen in hypoxemic tissues, and reduces blood coagulation phenomena in COVID-19 patients. Ozone has immunomodulatory effects by modulating cytokines (reduction of interleukin-1, interleukin-6, tumor necrosis factor-\u03b1, and interleukin-10), induction of interferon-\u03b3, anti-inflammatory properties by modulating NOD-, LRR- and pyrin domain-containing protein 3, inhibition of cytokine storm (blocking nuclear factor-\u03baB and stimulating nuclear factor erythroid 2-related factor 2 pathway), stimulates cellular/humoral immunity/phagocytic function and blocks angiotensin-converting enzyme 2. In direct oxygen-ozone injection, oxygen reacts with several biological molecules such as thiol groups in albumin to form ozonoids. Intravenous injection of ozonated saline significantly increases the length of time a person can remain hypoxic. The rectal ozone protocol is rectal ozone insufflation, resulting in clinical improvement in oxygen saturation and biochemical improvement (fibrinogen, D-dimer, urea, ferritin, LDH, interleukin-6, and C-reactive protein). In general, many studies have shown the positive effect of ozone therapy as a complementary therapy in the recovery of COVID-19 patients. All the findings indicate that systemic ozone therapy is nontoxic and has no side effects in these patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Yousefi", "ForeName": "Bahman", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Banihashemian", "ForeName": "Seyedeh Zahra", "Initials": "SZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Feyzabadi", "ForeName": "Zahra Khatibiyan", "Initials": "ZK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Mycology, Science and Research Branch, Islamic Azad University, Tehran, Iran."}], "LastName": "Hasanpour", "ForeName": "Sahar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran; Department of Oncology-Pathology, BioClinicum, Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden."}], "LastName": "Kokhaei", "ForeName": "Parviz", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Food Safety Research Center (Salt), Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Abdolshahi", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Deputy of Research and Technology, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Emadi", "ForeName": "Alireza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bacteriology and Virology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran."}], "LastName": "Eslami", "ForeName": "Majid", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Med Gas Res", "NlmUniqueID": "101564536", "ISSNLinking": "2045-9912"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Cytokine Release Syndrome"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Oxygen"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "\n<b>Conflicts of interest</b>\n. The authors have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tizaoui C. Ozone: A potential oxidant for COVID-19 virus (SARS-CoV-2) Ozone Sci Eng. 2020;42:378\u2013385."}, {"Citation": "Davidson AM, Wysocki J, Batlle D. Interaction of SARS-CoV-2 and other coronavirus with ACE (angiotensin-converting enzyme)-2 as their main receptor: therapeutic implications. Hypertension. 2020;76:1339\u20131349.", "ArticleIdList": ["PMC7480804", "32851855"]}, {"Citation": "Yousefi B, Valizadeh S, Ghaffari H, Vahedi A, Karbalaei M, Eslami M. A global treatments for coronaviruses including COVID-19. J Cell Physiol. 2020;235:9133\u20139142.", "ArticleIdList": ["PMC7273044", "32394467"]}, {"Citation": "Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584:457\u2013462.", "ArticleIdList": ["32668444"]}, {"Citation": "Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A collision of complement, coagulation and inflammatory pathways. J Thromb Haemost. 2020;18:2110\u20132117.", "ArticleIdList": ["PMC7361520", "32608159"]}, {"Citation": "Yousefi B, Eslami M. Genetic and structure of novel coronavirus COVID-19 and molecular mechanisms in the pathogenicity of coronaviruses. Rev Med Microbiol. 2021 doi: 10.1097/ MRM.0000000000000265."}, {"Citation": "Allam M, Cai S, Ganesh S, et al. COVID-19 diagnostics, tools, and prevention. Diagnostics (Basel) 2020;10:409.", "ArticleIdList": ["PMC7344926", "32560091"]}, {"Citation": "Mark A, Crumley JP, Rudolph KL, Doerschug K, Krupp A. Maintaining mobility in a patient who is pregnant and has COVID-19 requiring extracorporeal membrane oxygenation: a case report. Phys Ther. 2021;101:pzaa189.", "ArticleIdList": ["PMC7665742", "33395476"]}, {"Citation": "Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, et al. Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2021;21:167\u2013179.", "ArticleIdList": ["PMC7598940", "33128197"]}, {"Citation": "Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L, et al. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude. Respir Physiol Neurobiol? 2020;277:103443.", "ArticleIdList": ["PMC7175867", "32333993"]}, {"Citation": "Semple JL, Moore GWK. High levels of ambient ozone (O3) may impact COVID-19 in high altitude mountain environments. Respir Physiol Neurobiol. 2020;280:103487.", "ArticleIdList": ["PMC7324919", "32619691"]}, {"Citation": "Srivastava S, Garg I, Bansal A, Kumar B. SARS-CoV-2 infection: physiological and environmental gift factors at high altitude. Virus-disease. 2020;31:1\u20133.", "ArticleIdList": ["PMC7485422", "32953947"]}, {"Citation": "Gavazza A, Marchegiani A, Rossi G, et al. Ozone therapy as a possible option in COVID-19 management. Front Public Health. 2020;8:417.", "ArticleIdList": ["PMC7477102", "32984235"]}, {"Citation": "Ghude SD, Jena C, Chate DM, et al. Reductions in India\u2019s crop yield due to ozone. Geophys Res Lett. 2014;41:5685\u20135691."}, {"Citation": "Rowen RJ, Robins H. A plausible \u201cpenny\u201d costing effective treatment for corona virus - ozone therapy. J Infect Dis Epidemiol. 2020;6:113."}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Schwartz A, Donna VD. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel) 2020;9:389.", "ArticleIdList": ["PMC7278582", "32384798"]}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, Pe\u00f1a-Lora D, \u00c1lava-Rabasa S, P\u00e9rez-Moro OS. Ozone (O3) and SARS-CoV-2: physiological bases and their therapeutic possibilities according to COVID-19 evolutionary stage. SN Compr Clin Med. 2020;doi:10. doi: 10.1007/s42399-020-00328-7.", "ArticleIdList": ["PMC7340747", "32838159"]}, {"Citation": "Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. 2020;24:4059\u20134061.", "ArticleIdList": ["32374009"]}, {"Citation": "LeBaron TW, Kura B, Kalocayova B, Tribulova N, Slezak J. A new approach for the prevention and treatment of cardiovascular disorders. molecular hydrogen significantly reduces the effects of oxidative stress. Molecules. 2019;24:2076.", "ArticleIdList": ["PMC6600250", "31159153"]}, {"Citation": "Cattel F, Giordano S, Bertiond C, et al. Ozone therapy in COVID-19: A narrative review. Virus Res. 2021;291:198207.", "ArticleIdList": ["PMC7585733", "33115670"]}, {"Citation": "Sagai M, Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress. Med Gas Res? 2011;1:29.", "ArticleIdList": ["PMC3298518", "22185664"]}, {"Citation": "Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. 2020;92:2348\u20132350.", "ArticleIdList": ["PMC7280732", "32437014"]}, {"Citation": "Ricevuti G, Franzini M, Valdenassi L. Oxygen-ozone immunoceutical therapy in COVID-19 outbreak: facts and figures. Ozone Ther. 2020;5:9014."}, {"Citation": "Levanov AV, Isaikina OY, Gasanova RB, Lunin VV. Solubility of ozone and kinetics of its decomposition in aqueous chloride solutions. Ind Eng Chem Res. 2018;57:14355\u201314364."}, {"Citation": "Viebahn-H\u00e4nsler R, Le\u00f3n Fern\u00e1ndez OS, Fahmy Z. Ozone in medicine: clinical evaluation and evidence classification of the systemic ozone applications, major autohemotherapy and rectal insufflation, according to the requirements for evidence-based medicine. Ozone Sci Eng. 2016;38:322\u2013345."}, {"Citation": "Thorp JA, Hollonbeck SA, Viglione DD, et al. Novel therapy for COVID-19 does intravenous ozonated-saline affect blood and tissue oxygenation. J Gynecol Res Obstet? 2020;6:046\u2013050."}, {"Citation": "Kapiciba\u015fi HO, Kiraz HA, Demir ET, Adali Y, Elmas S. Pulmonary effects of ozone therapy at different doses combined with antibioticotherapy in experimental sepsis model. Acta Cir Bras. 2020;35:e202000604.", "ArticleIdList": ["PMC7357834", "32667585"]}, {"Citation": "Schulz S, Rodriguez ZZ, Mutters R, Menendez S, Bette M. Repetitive pneumoperitoneum with ozonized oxygen as a preventive in lethal polymicrobial sepsis in rats. Eur Surg Res. 2003;35:26\u201334.", "ArticleIdList": ["12566784"]}, {"Citation": "Ranaldi GT, Villani ER, Franza L, Motola G. Devils and angels: ozonetherapy for microcirculation in COVID-19. Frenxiv. 2020;doi:10. 31226/osf.io/c2jvt."}, {"Citation": "de Haan CA, Kuo L, Masters PS, Vennema H, Rottier PJ. Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol. 1998;72:6838\u20136850.", "ArticleIdList": ["PMC109893", "9658133"]}, {"Citation": "Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci. 1999;56:270\u2013279.", "ArticleIdList": ["10795372"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, et al. Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID- 19. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879.", "ArticleIdList": ["PMC7414302", "32795898"]}, {"Citation": "Obeid BMA. Ozone autohemotherapy: possible mechanisms of anti-viral action and anti oxidative. J Infect Dis Epidemiol. 2020;6:117."}, {"Citation": "Al-Motawa MS, Abbas H, Wijten P, et al. Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity-opportunity for repurposed chemotherapy of COVID-19 infection. Front Pharmacol. 2020;11:585408.", "ArticleIdList": ["PMC7581855", "33162891"]}, {"Citation": "Fakhrzadeh L, Laskin JD, Laskin DL. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am J Respir Cell Mol Biol. 2002;26:413\u2013419.", "ArticleIdList": ["11919077"]}, {"Citation": "Suh Y, Patel S, Kaitlyn R, et al. Clinical utility of ozone therapy in dental and oral medicine. Med Gas Res. 2019;9:163\u2013167.", "ArticleIdList": ["PMC6779001", "31552882"]}, {"Citation": "Di Mauro R, Cantarella G, Bernardini R, et al. The biochemical and pharmacological properties of ozone: the smell of protection in acute and chronic diseases. Int J Mol Sci. 2019;20:634.", "ArticleIdList": ["PMC6387239", "30717203"]}, {"Citation": "\u00c7ak\u0131r T, Aslaner A, Tekeli S, et al. Effect of ozone on colon anastomoses in rat peritonitis model. Acta Cir Bras. 2016;31:111\u2013118.", "ArticleIdList": ["26959620"]}, {"Citation": "Rosanna DP, Salvatore C. Reactive oxygen species, inflammation, and lung diseases. Curr Pharm Des. 2012;18:3889\u20133900.", "ArticleIdList": ["22632750"]}, {"Citation": "Menendez-Cepero S, Marques-Magallanes-Regojo JA, Hernandez-Martinez A, Tall\u00f3n FJH, Baeza-Noci AJ. Therapeutic effects of ozone therapy that justifies its use for the treatment of COVID-19. J Neurol Neurocrit Care. 2020;3:1\u20136."}, {"Citation": "Ferrara F, Pambianchi E, Pecorelli A, et al. Redox regulation of cutaneous inflammasome by ozone exposure. Free Radic Biol Med. 2020;152:561\u2013570.", "ArticleIdList": ["31778733"]}, {"Citation": "L\u00f3pez A, Martinson SA. Respiratory system, mediastinum, and pleurae. Pathologic Basis Vet Dis. 2017;471:560.e1."}, {"Citation": "Araimo F, Imperiale C, Tordiglione P, et al. Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial. J Med Virol. 2021;93:2210\u20132220.", "ArticleIdList": ["33111980"]}, {"Citation": "Juchniewicz H, Lubkowska A. Oxygen-ozone (O(2)-O(3)) Therapy in peripheral arterial disease (PAD): a review study. Ther Clin Risk Manag. 2020;16:579\u2013594.", "ArticleIdList": ["PMC7334138", "32636631"]}, {"Citation": "Hiroshi T, Miei S, Kousuke I, Yoshiaki M. Inactivation of influenza virus by ozone gas. IHI Eng Rev. 2009;42:108\u2013111."}, {"Citation": "Murray BK, Ohmine S, Tomer DP, et al. Virion disruption by ozonemediated reactive oxygen species. J Virol Methods. 2008;153:74\u201377.", "ArticleIdList": ["18598719"]}, {"Citation": "Hudson JB, Sharma M, Vimalanathan S. Development of a practical method for using ozone gas as a virus decontaminating agent. Ozone Sci Eng. 2009;31:216\u2013223."}, {"Citation": "Fern\u00e1ndez-Cuadros ME, Albaladejo-Flor\u00edn MJ, \u00c1lava-Rabasa S, et al. Effect of rectal ozone (O(3)) in severe COVID-19 pneumonia: preliminary results. SN Compr Clin Med. 2020;2:1328\u20131336.", "ArticleIdList": ["PMC7397966", "32838181"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Isidoro T, Vil\u00e1s F. Potential role of oxygen-ozone therapy in treatment of COVID-19 pneumonia. Am J Case Rep. 2020;21:e925849.", "ArticleIdList": ["PMC7476746", "32804917"]}, {"Citation": "Wang Z, Wang J, He J. Active and effective measures for the care of patients with cancer during the COVID-19 spread in China. JAMA Oncol. 2020;6:631\u2013632.", "ArticleIdList": ["32236504"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "22", "Hour": "12", "Minute": "16"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34677149", "PMC8562402", "10.4103/2045-9912.325989", "MedGasRes_2022_12_2_33_325989"]}}], "PubmedBookArticle": []}